Press Releases
A Broader Audience of Investors is Expected to Expand our Shareholder Base and Enhance Trading Liquidity
BIRMINGHAM, AL / ACCESSWIRE / May 29, 2024 / Diversified Energy Company PLC (LSE: DEC);(NYSE: DEC) ("Diversified" or the "Company") today announced that as part of the annual reconstitution of the Russell stock indexes, Diversified is to be included in the Russell 2000� Index effective at the open of US equity markets on Monday, July 1st, 2024 according to the... (continue reading...)
Digital tool gives real-time feedback on the impact of changes to clinical study protocols, helping clinical teams reduce the cost, duration and burden of studies on sponsors, sites and patients.
SAN DIEGO, CA / ACCESSWIRE / May 29, 2024 / A new study, published in the peer-reviewed journal Therapeutic Innovation & Regulatory Science and conducted in collaboration with Merck, shows that when Faro's Study Designer Tool was applied to clinical trial protocol development... (continue reading...)
MONTRÉAL, May 29, 2024 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or the “Company”) today announced that the eight director nominees, being all of the existing directors of the Company following the resignation on May 23, 2024 of the prior members of the board of directors, were elected as directors of the Company for the ensuing year by an overwhelming majority of the votes cast by shareholders, in-person, and by proxy, at its... (continue reading...)
VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- Sable Resources Ltd. ("Sable" or the "Company") (TSXV:SAE | OTCQB: SBLRF) is pleased to announce that it has staked 4,806 hectares of prospective ground in two properties located NW and SE of the Perk Rocky Project in British Columbia.
Dr. Ruben Padilla, President and CEO of Sable stated, “Following the Company’s entering into the option agreement for the Perk Rocky Project, Sable is pursuing... (continue reading...)
VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- ValOre Metals Corp. (“ValOre”, or the “Company”) (TSX-V: VO, OTCQB: KVLQF, Frankfurt: KEQ0) today provided an update regarding its Hatchet Lake Uranium Property.
Jim Paterson, Chairman and CEO, ValOre Metals Corp. stated: “We have partnered with knowledgeable investors with significant experience in Canada’s uranium exploration sector to help unlock value from our highly prospective Hatchet... (continue reading...)
More Press Releases
View Older Stories-
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
-
Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
-
Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
-
Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI Officer
-
LiTHOS Announces Executive Team Expansion to Accelerate Growth in the Sustainable Lithium Sector and Financing Closure
-
NSM Insurance Group Acquires Two Leading U.K. Travel Insurance Brands
-
Gatorade's Iconic "Is It In You?" Tagline Returns for Largest Campaign in Brand History
-
ProKidney to Participate in the Jefferies Global Healthcare Conference
-
DICK'S Sporting Goods Reports First Quarter Results; Raises 2024 Outlook
-
The Habit Burger Grill Opens New Drive-Thru in Fresno, Its Fifth Location in the California City
-
Keeper Unveils Revamped Browser Extension to Improve Usability
-
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
-
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
-
Toyota Announces First Communities to Receive DC Fast Chargers Through 'Empact' Vision
-
Torus Signs 26 MWh Energy Storage Deal With Gardner Group
-
Viking Reports First Quarter 2024 Financial Results
-
Talen Energy Corporation Commences a Tender Offer to Repurchase up to $600,000,000 of its Common Stock
-
Nanoscope Therapeutics to Present at the BIO International Convention
-
Monteloeder by Suannutra's Lemon Verbena Extract May Help You Sleep More Soundly New Study Suggests
-
ABBYY Recognized as a Leader in Everest Group’s Intelligent Document Processing Products PEAK Matrix® Assessment 2024 for Sixth Consecutive Year
-
Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy
-
Bybit Offers Exclusive P2P Trading Rewards with A 6,000 USDT Prize Pool for Selected Users
-
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
-
Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
Windward Launches Organization Defined Risk, Setting a New Standard of Risk Management with Automated, Configurable Parameters
-
Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases
-
ConocoPhillips to acquire Marathon Oil Corporation in all-stock transaction; provides shareholder distribution update
-
PANERA IS IN ITS MORE IS MORE ERA WITH THE MOST VALUABLE UNLIMITED SIP CLUB OFFER TO-DATE JUST IN TIME FOR SUMMER
-
Vetsource launches third pet pharmacy to support customer growth
-
bluebird bio Appoints O. James Sterling as Chief Financial Officer
-
Davies’ Evaluation Endorses DataVisor’s Enhanced AML/BSA Solutions, Affirming Operational Integrity and Seamless Investigation Processes for FIs
-
TrueBlue's PeopleReady Skilled Trades Honors Careers in the Trades Amidst Skilled Labor Shortage
-
ReposiTrak Adds 25 New Produce Companies to the Queue for the Rapidly Expanding Food Traceability Network
-
The City of Orlando Partners With AI Startup PETE To Scale Workforce Learning Of Kia Center and Camping World Stadium
-
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
-
Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data
-
Origin Materials and Bachmann Group to Mass Produce PET Caps and Closures
-
Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
CHRIS HEMSWORTH, CHRISTINA RICCI, KEN JEONG, WILL ARNETT AND AULI'I CRAVALHO SQUAD UP WITH SUPERCELL FOR GLOBAL GAME LAUNCH
-
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
-
Trinity Lutheran School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students
-
Plum Teams Up with hireEZ to Improve Recruiting Outcomes Through Job Matching
-
AGI Responds to Media Report of Unsolicited Proposal
-
Alentis Receives FDA Orphan Drug Designation for Lixudebart to Treat Idiopathic Pulmonary Fibrosis
-
Ryan Named to Newsweek’s America’s Greatest Workplaces 2024 for Mental Wellbeing
-
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
-
Grey Wolf Therapeutics to Present First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting
-
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
-
Aethon Energy to Acquire Tellurian Integrated Upstream Assets
-
Climate Tech VC Clean Energy Ventures Closes $305M Fund II Aiming to Mitigate 75 Gigatons of Emissions by 2050
